Co-Diagnostics Highlights PCR Platform Capabilities for Potential Plague Detection

Summary

Co-Diagnostics highlights its PCR platform capabilities for potential plague detection, leveraging existing sputum sample-preparation technology and rapid-response experience from COVID-19, Mpox, and Ebola. The company emphasizes its expanded manufacturing infrastructure as a foundation for developing plague diagnostics.